At a glance
- Originator Pierrel
- Class Antihyperlipidaemics; Benzoic acids
- Mechanism of Action Cholesterol inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia
Most Recent Events
- 20 Feb 1995 Discontinued-I for Hyperlipidaemia in Italy (Unknown route)